Translational Research And Innovations Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 3 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
About Translational Research And Innovations
Translational Research And Innovations Private Limited (TRAIPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 08 June 2021 (Three years and eight months 15 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Alok Adholeya, Akshun Abhimanyu, and Radhika Adholeya serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U73100DL2021PTC382061
- Company No.
382061
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Jun 2021
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Translational Research And Innovations?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Radhika Adholeya  | Director | 08-Jun-2021 | Current |
| Akshun Abhimanyu | Whole-Time Director | 24-Sep-2021 | Current |
| Alok Adholeya | Director | 08-Jun-2021 | Current |
Financial Performance of Translational Research And Innovations.
Translational Research And Innovations Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Translational Research And Innovations?
Unlock access to Translational Research And Innovations's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Umahari Private LimitedAlok Adholeya is a mutual person
- Zenmatic Private Limited
Radhika Adholeya is a mutual person
- Uwc Healthcare Private Limited
Radhika Adholeya is a mutual person
- Fem World Foundation
Radhika Adholeya is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Translational Research And Innovations?
Translational Research And Innovations has a workforce of 8 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Translational Research And Innovations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Translational Research And Innovations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.